SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 229 filers reported holding SANGAMO THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.52 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $105,000 | -98.8% | 11,127 | -99.2% | 0.00% | -98.9% |
| Q1 2020 | $8,683,000 | +215.1% | 1,363,039 | +313.9% | 0.09% | +357.9% |
| Q4 2019 | $2,756,000 | +840.6% | 329,326 | +917.8% | 0.02% | +850.0% |
| Q3 2019 | $293,000 | -96.4% | 32,358 | -95.5% | 0.00% | -97.6% |
| Q4 2018 | $8,181,000 | +1678.5% | 712,657 | +2526.2% | 0.08% | +4100.0% |
| Q3 2018 | $460,000 | -9.3% | 27,136 | -51.8% | 0.00% | -90.9% |
| Q2 2017 | $507,000 | – | 56,314 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Golden State Equity Partners | 154,360 | $897,000 | 0.45% |
| Rhenman & Partners Asset Management AB | 761,429 | $4,424,000 | 0.44% |
| Lombard Odier Asset Management (Switzerland) SA | 860,702 | $5,001,000 | 0.39% |
| WASATCH ADVISORS LP | 10,576,997 | $61,452,000 | 0.30% |
| Rokos Capital Management LLP | 977,663 | $5,861,000 | 0.27% |
| KLK CAPITAL MANAGEMENT LLC | 44,323 | $258,000 | 0.26% |
| Long Focus Capital Management, LLC | 340,000 | $1,975,000 | 0.25% |
| Vanguard Capital Wealth Advisors | 33,380 | $193,000 | 0.14% |
| Fort Sheridan Advisors LLC | 73,978 | $430,000 | 0.13% |
| Delphia (USA) Inc. | 20,983 | $122,000 | 0.09% |